Podcast
 |
| Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
Annual Biotechnology Industry Reports
Biotech 2010 Life Sciences: Adapting for Success (Print and PDF Bundle) › Learn More
Add to cart$370.00
Biotech 2009-Life Sciences: Navigating the Sea Change (Print and Electronic) › Learn More
Add to cart$695.00
Biotech 2008: A 20/20 Vision To 2020 (Print) Biotech 2008 – Life Sciences: A 20/20 Vision to 2020 is Burrill & Company's 22nd annual report on the state of the biotech industry, highlighting the critical developments in 2007. This edition has a special focus on the future and looks forward just over a decade at the projected environment for the industry in the year 2020…and develops the pathway that will lead us there. › Learn More
Add to cart$430.00
Biotech 2008: A 20/20 Vision To 2020 (Online)
This edition has a special focus on the future and looks forward just over a decade at the projected environment for the industry in the year 2020…and develops the pathway that will lead us there.
*Single User Access only. For Multiple User rates contact
pwinter@b-c.com
› Learn More
Add to cart$295.00
State-of-the-Industry at BIO International Convention 2008 The biotechnology industry's leading expert and visionary G. Steven Burrill, CEO of Burrill & Company spoke about the future of the biotechnology industry at BIO 2008. Mr. Burrill reflected on the events that occurred during the 13 months that have elapsed since BIO 2007 and presented insightful data on the financial performance of the biotechnology industry. Building on these statistics he provided his predictions for the rest of the year and his visions for the industry in 2020. Mr. Burrill's presentation (184 slides) are available free-of-charge with the purchase of Biotech 2008, or may be ordered by clicking the checkout button below. › Learn More
Add to cart$250.00
BIOTECH 2007 (Print) The 21st Edition of BIOTECH 2007 focuses on the emergence of biotechnology as a global industry. This publication provides an overview of the latest developments and trends in biotech around the world along with detailed analysis on the progress and prospects for each nation reviewed. › Learn More
Add to cart$235.00
BUNDLE: Biotech 2008: A 20/20 Vision To 2020 (Print and Online)
In an industry where change is a constant, Biotech 2008 is the industry’s “roadmap” and a must read for all those interested in the revolution taking place in the life sciences world…changing the way we heal the world, feed the world, and fuel the world.
*Single User Access only. For Multiple User rates contact pwinter@b-c.com
› Learn More
Includes
 | Biotech 2008: A 20/20 Vision To 2020 (Print) |
| Biotech 2008: A 20/20 Vision To 2020 (Online) |
Add to cart$680.00
BUNDLE: Burrill Biotech 2008 and 2007 BUNDLE
Biotech 08 (Print and Online*)
Includes
| Biotech 2008: A 20/20 Vision To 2020 (Print) |
| Biotech 2008: A 20/20 Vision To 2020 (Online) |
 | BIOTECH 2007 (Print) |
Add to cart$530.00